ALPHA | ALPHA IVF GROUP BERHAD [NS]
0.280 (1.82%)
T-O (am): 0.280 (08:59:00)T-O (pm): 0.280 (14:29:00)
Price updated as of: 15:33
Fundamental
Technical
Total Score
ALPHA [NS] Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
ALPHA [NS] Quarter Reports
Customize
Select columns required and click "Update" to save your preferences
| Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22 Jan 26 | Q2 Nov 2025 | 2 | 31 May 2026 | 47.30 | 16.47 | 12.00 | 25.4% | 0.00 | 0.25 | 9.2% | 9.4% | 21.5% | 20.5% | ||||||||
| 28 Oct 25 | Q1 Aug 2025 | 1 | 31 May 2026 | 52.09 | 20.98 | 15.28 | 29.3% | 0.50 | 0.31 | 4.2% | 21.2% | 4.9% | 6.2% | ||||||||
| 28 Jul 25 | Q4 May 2025 | 4 | 31 May 2025 | 50.01 | 21.37 | 16.07 | 32.1% | 0.00 | 0.33 | 23.2% | 7.0% | 35.0% | 14.7% | ||||||||
| 22 Apr 25 | Q3 Feb 2025 | 3 | 31 May 2025 | 40.60 | 15.58 | 11.90 | 29.3% | 0.50 | 0.24 | 6.1% | 0.3% | 21.2% | 12.4% | ||||||||
| 21 Jan 25 | Q2 Nov 2024 | 2 | 31 May 2025 | 43.24 | 20.19 | 15.10 | 34.9% | 0.00 | 0.31 | 0.6% | 12.2% | 5.0% | 23.6% | ||||||||
| 21 Oct 24 | Q1 Aug 2024 | 1 | 31 May 2025 | 42.99 | 19.00 | 14.38 | 33.5% | 0.45 | 0.30 | 8.0% | 2.7% | ||||||||||
| 17 Jul 24 | Q4 May 2024 | 4 | 31 May 2024 | 46.74 | 19.42 | 14.01 | 30.0% | 0.00 | 0.29 | 14.8% | 3.1% | ||||||||||
| 16 Apr 24 | Q3 Feb 2024 | 3 | 31 May 2024 | 40.70 | 18.01 | 13.59 | 33.4% | 0.49 | 0.30 | 5.6% | 11.2% | ||||||||||
| 18 Mar 24 | Q2 Nov 2023 | 2 | 31 May 2024 | 38.54 | 16.64 | 12.21 | 31.7% | 0.21 | 0.27 |
ALPHA [NS] Historical Dividends
ALPHA [NS] Financial Ratios
| EPS | 1.14 sen |
| Trailing PE (Sector Median: 26.9) | 24.6 |
| PEG | 24.6 |
| Altman Z | 2.4 |
| Beaver | 0.382 |
| Current Ratio | 5.63 |
| Debt-Equity (DE) Ratio | 0.3 |
| FCF Yield | 0.81 % |
| Revenue QoQ | -9.21 % |
| Revenue YoY | 9.38% |
| Profit QoQ | -21.48 % |
| Profit YoY | -20.54 % |
| Profit Margin (Sector Median: 7.6) | 29.08 % |
| ROE (ROIC: 28.1) | 28.1 % |
| Dividend Per Share (DPS) | 1.0 sen |
| Dividend Yield (DY) | 3.57 % |
ALPHA [NS] Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 26.9) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 7.6) | |
| ROE (ROIC: 28.59) | |
| Altman Z |
ALPHA [NS] Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation | |
| Average Analysts FV based on 3 rating(s) |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.04 | Consistent QR FV |
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | 12.33 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0 |
| Expected Revenue (M) | 0 |
| Expected Growth (%) | 0 |
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research
ALPHA [NS] Directors Share Purchases (Beta)
No transaction in the last 2 months.
ALPHA [NS] Summary
Market Cap: 1360 M.
Market Cap Class: Middlers
Number of Shares: 4860 M.
Adjusted Float: 0%.
Alpha IVF Group Berhad is a leading provider of assisted reproductive services (ARS). The company specializes in advanced fertility treatments such as in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT). Alpha IVF also offers a range of supporting medical services, including andrology, embryology, and cryopreservation, catering to individuals and couples facing fertility challenges. With state-of-the-art laboratory facilities and a team of experienced medical specialists, the group emphasizes innovative and patient-centered care. Committed to excellence in reproductive healthcare, Alpha IVF serves a diverse clientele, locally and internationally, with a focus on achieving positive patient outcomes and advancing fertility science. Alpha IVF was incorporated in 2021 and headquartered in Petaling Jaya, Selangor, Malaysia.
Sectors: Healthcare, Health Care Providers, Penny Stocks
Code: 0303
Website: http://www.alphaivfgroup.com
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed
ALPHA [NS] Top Shareholdings
Updated on 27-Jan-2026
| Shareholder | % | Value (M) |
|---|---|---|
| Dato' Dr Lee Soon Soo | 35.17% | 478.58 |
| Ace Specialists Sdn Bhd | 9.22% | 125.49 |
Frequently Asked Questions
Alpha IVF Group Berhad is a leading provider of assisted reproductive services (ARS). The company specializes in advanced fertility treatments such as in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT). Alpha IVF also offers a range of supporting medical services, including andrology, embryology, and cryopreservation, catering to individuals and couples facing fertility challenges. With state-of-the-art laboratory facilities and a team of experienced medical specialists, the group emphasizes innovative and patient-centered care. Committed to excellence in reproductive healthcare, Alpha IVF serves a diverse clientele, locally and internationally, with a focus on achieving positive patient outcomes and advancing fertility science. Alpha IVF was incorporated in 2021 and headquartered in Petaling Jaya, Selangor, Malaysia. The company is listed on Bursa Malaysia and operates in the Healthcare, Health Care Providers and Penny Stocks sectors.
No, ALPHA IVF GROUP BERHAD is not Shariah-compliant.
The latest share price of ALPHA IVF GROUP BERHAD is RM 0.280 updated on 28 January 2026 15:33.
As of now, ALPHA IVF GROUP BERHAD has a market capitalization of 1360M based on the latest financial data.
iSaham's technical analysis indicates that ALPHA IVF GROUP BERHAD's support level is at RM 0.28 and its resistance level is at RM 0.3, based on moving averages and price patterns.
The 52-week high for ALPHA IVF GROUP BERHAD is RM 0.31
ALPHA IVF GROUP BERHAD's share price has decreased by -11.11% year-to-date, influenced by market trends and company performance.
ALPHA IVF GROUP BERHAD declared a dividend of 1.0 sen for the year 2026-01-22. View more details on ALPHA IVF GROUP BERHAD's Historical Dividends page.
The main shareholders of ALPHA IVF GROUP BERHAD include Dato' Dr Lee Soon Soo and Ace Specialists Sdn Bhd. View more on ALPHA IVF GROUP BERHAD Top Shareholders page.
You can buy ALPHA IVF GROUP BERHAD shares through any licensed online broker or trading platform registered with Bursa Malaysia. If you're new to investing, iSaham can help you open an account with M+ Online, one of Malaysia's leading brokers.
When you open your M+ account through the iSaham team, you can get iSaham Pro for free as a bonus offer.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.